William G. Rice - 06 Jun 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role: Chair, President & CEO, Director
Signature: /s/ Janet Clennett as attorney-in-fact for William G. Rice
Issuer symbol: APTOF
Transactions as of: 06 Jun 2022
Net transactions value: +$9,681
Form type: 4
Filing time: 06 Jun 2022, 16:13:34 UTC
Previous filing: 20 Jan 2022
Next filing: 07 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APTO	Common Shares	Purchase	$9,681	+10,000	+2.9%	$0.9681^*	353,252	06 Jun 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9651 to $0.9702, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9651 to $0.9702, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.